Vis enkel innførsel

dc.contributor.authorFoss, Olav A.
dc.contributor.authorMjønes, Patricia
dc.contributor.authorFismen, Silje
dc.contributor.authorChristensen, Eidi
dc.date.accessioned2020-03-04T12:19:07Z
dc.date.available2020-03-04T12:19:07Z
dc.date.created2016-03-05T12:14:12Z
dc.date.issued2016
dc.identifier.citationJournal of Skin Cancer. 2016, 2016:6146091 .nb_NO
dc.identifier.issn2090-2905
dc.identifier.urihttp://hdl.handle.net/11250/2645233
dc.description.abstractBasal cell carcinoma (BCC) is an invasive epithelial skin tumour. The thickness of the outermost epidermal layer of the skin, the stratum corneum (SC), influences drug uptake and penetration into tumour and may thereby affect the response of BCC to topical treatment. The aim was to investigate a possible relationship between the thickness of the SC and that of the viable part of BCC. Histopathological evaluations of the corresponding SC and viable tumour thickness measurements of individual BCCs of different subtypes were explored. A total of 53 BCCs from 46 patients were studied. The median tumour thickness was 1.7 mm (0.8–3.0 mm), with a significant difference between subtypes (𝑝� < 0.001). The SC had a median thickness of 0.3 mm (0.2–0.4 mm), with no difference between tumour subtypes (𝑝� = 0.415). Additionally, no significant association between the thickness of the SC and that of the viable part of the tumour was demonstrated (𝑝� = 0.381). In conclusion our results indicate that SC thickness is relatively constant in BCC.nb_NO
dc.language.isoengnb_NO
dc.publisherHindawi Publishing Corporationnb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleIs there a relationship between the stratum corneum thickness and that of the viable parts of tumour cells in basal cell carcinoma?nb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.subject.nsiVDP::Dermatologi og venerologi: 753nb_NO
dc.subject.nsiVDP::Dermatology and venereology: 753nb_NO
dc.source.pagenumber5nb_NO
dc.source.volume2016:6146091nb_NO
dc.source.journalJournal of Skin Cancernb_NO
dc.identifier.doi10.1155/2016/6146091
dc.identifier.cristin1342405
dc.description.localcode© 2016 Olav A. Foss et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.nb_NO
cristin.unitcode1920,9,0,0
cristin.unitcode1920,14,0,0
cristin.unitcode194,65,15,0
cristin.unitnameKlinikk for ortopedi, revmatologi og hudsykdommer
cristin.unitnameLaboratoriemedisinsk klinikk
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal